SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IVX: IVAX Corporation
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
78 6 0 IVX
Emcee:  SI (no user) Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
28IVAX Submits ANDA For Generic Equivalent Of Flonase DOW JONES NEWSWIRES MIAMI -Jim Oravetz-3/7/2003
27IVAX 4Q EPS 19c DOW JONES NEWSWIRES IVAX Corp. - Miami <pre> 4th Jim Oravetz-2/13/2003
26IVAX To Develop New HIV Drug DOW JONES NEWSWIRES MIAMI -- Ivax Corp. (IVX), aloJim Oravetz-1/31/2003
25IVAX Acquires Maker Of Active Pharmaceutical Ingredients DOW JONES NEWSWIRES MIJim Oravetz-1/27/2003
24Message 18136861Jim Oravetz-10/24/2002
23Ivax Corp. (IVX), of Miami, is expected to earn 14 cents a share on revenue of $Jim Oravetz-7/17/2002
22Taking the Cure:Ivax's shares may be sickly, but the generic drug maker'Jim Oravetz-7/8/2002
21Ivax CEO Frost Buys 50,000 Shares Through Partnership DOW JONES NEWSWIRES WASHIJim Oravetz-5/21/2002
20IVAX Corp Gets FDA Pediatric OK For QVAR DOW JONES NEWSWIRES MIAMI -- IVAX CorpJim Oravetz-5/14/2002
19IVAX Launches Two Proprietary Asthma Pdts in Mexico DOW JONES NEWSWIRES MIAMI -Jim Oravetz-5/10/2002
18Napro Up 57% After FDA Mktg Ok For Generic Cancer Drug DOW JONES NEWSWIRES NEW Jim Oravetz-5/10/2002
17Abbott Laboratories (ABT) And NaPro BioTherapeutics (NPRO) Receive FDA Approval Jim Oravetz-5/9/2002
16SeniOT:Drug Firm Taken to Task by FTC For Tactic to Keep Generic at Bay By GARDIJim Oravetz-4/24/2002
15UK Drug Fraud Allegations Sting Cos At Home, Abroad By SUSANNAH RODGERS Of DOW JJim Oravetz-4/10/2002
14When you compare the PE of this stock to other generic drug stocks (like mylan) Jim Oravetz-4/5/2002
13Jim, is this a value stock? Why are the multiples so low for IVX? Hitting new lTed The Technician-4/4/2002
12French Generics Market To Double By 2005 - Industry Execs DOW JONES NEWSWIRES Jim Oravetz-4/4/2002
11Ivax Corp., 3M In QVAR Inhaler U.S. Pact DOW JONES NEWSWIRES MIAMI -- Ivax CorpJim Oravetz-4/2/2002
10Ivax Corp Sees $80M-$90M In 2002 For Facility Upgrades DOW JONES NEWSWIRES WASHJim Oravetz-3/29/2002
9Ivax Dn 9%; UBS In Downgrade Cites Slow Pipeline DOW JONES NEWSWIRES By DanJim Oravetz-3/27/2002
8Ivax's E2CDS Suppressed Hormone Levels In Pilot Study DOW JONES NEWSWIRES MJim Oravetz-3/21/2002
7SemiOT:States Are Finding Generic Drugs Can Cost More Than Brand Name By ANDREW Jim Oravetz-2/13/2002
6FDA Status Resolved - IVAX' Generic Paclitaxel On the Market to Stay MIAMIJim Oravetz-1/29/2002
5NEW YORK, Jan 15 (Reuters) - Generic drugmaker Ivax Corp. (IVX,Trade) said on TuJim Oravetz-1/21/2002
4Generic Drug Makers Win Court Victories, Strengthening Position Against Brand RiJim Oravetz-1/15/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News